Anti-ischemic therapy, in particular beta-blockers, is the most commonly employed drug for the control of myocardial ischemia in patients with stable coronary artery disease.
Advancing global health through high-quality APIs, intermediates, and surgical products. Trusted solutions driven by innovation, quality, and care.
Copyright © 2025 Healnith Pharmaceuticals All rights reserved.